Abstract
The search for immunosuppressant drugs to increase the success of organ transplantation led to the discovery of the immunophilins, proteins that interface with a range of signal transduction systems inside cells, especially in the nervous and immune systems. Here we review how these interesting molecules work and consider their therapeutic potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
F.S., Palmer, R.M.J. & Higgs, E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109–142 (1991).
Dawson, T.M. & Snyder, S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurvsci. 14, 5147–5159 (1994).
Handschumacher, R.E., Harding, M.W., Rice, J., Drugge, R.J. & Speicer, D.W. Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 226, 544–547 (1984).
Fischer, G., Bang, H. & Mech, C. Determination I of enzymatic catalysis for the cis-fraws-isomerization of peptide binding in projine-containing peptides. Biomed. Biochim. Acta. 43, 1101–1111 (1984).
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T. & Schmid, F.X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 340, 351–352 (1989).
Steinmann, B., Bruckner, P. & Superti-Furga, P. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiological role of peptidyl-prolyl cis-trans-isomerase. J. biol. Chem. 266, 1299–1303 (1991).
Lodish, H.F. & Kong, N. Cyclosporin A inhibits an i litial step in folding of transferrrin within the endoplasmic reticulum. J. biol. Chem. 266, 14835–14838 (1991).
Ochiai, T., K., Nakajima & Nagat, M. Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation I in the rat. Transplant Proc. 19, 1284–1286 (1987).
Siekierka, J.J., Hung, S.H.Y., Poe, M., Lin, C.S. & Sigal, N.H. A cytosolic binding protein for the immunosuppressant FK506 has peptk y1-proly1 isomerase activity but is distinct from cyclophilin. Nature 341, 755–757 (1989).
Harding, M.W., Galat, A., Uehling, D.E. & Schreiber, S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341, 758–760 (1989).
Bierer, B.E. et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunmophilin and either FK506 and rapamycin. Proc. natn. Acad. Sci. U.S.A. 87, 9231–9235 (1990).
Schreiber, S.L. Chemistry and biology of the immunophilms and their immunosuppressive ligands. Science 253, 283–287 (1991).
Dumont, et al. et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: Pharmacology of a novel antagonist of FK-506 and rapamycin. J. exp. Med. 176, 751–760 (1992).
Bierer, B.E. et al. Probining immunosuppressant action with a non-natural im-munophilin ligand. Science 250, 556–559 (1990).
Arber, S., Krause, K.H. & Caroni, P. S-cyclosporin is retained intracellularly via a unique COOH-terminal sequence and co-localizes with the calcium storage protein calreticulin. J. cell Biol. 116, 113–125 (1992).
Bram, R.J., Hung, D.T., Martin, P.K., Schreiber, S.L. & Crabtree, R. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. cell Biol. 13, 4760–4769 (1993).
Bergsma, D.J. et al The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. J. biol Chem. 266, 23204–23214 (1991).
Kieffer, L.J. et al. Cyclophilin-40, a protein with homology to the P59 component of the steroid receptor complex. Cloning of the cDNA and further characterization. J. biol. Chem. 268, 12303–12310 (1993).
Jin, Y.-J. et al. Molecular cloning of a membrane-associated human FK506-and rapamycin-binding protein, FKBP-13. Proc. natn. Acad. Sci. U.S.A. 88, 6677–6681 (1991).
Tottrup, A., Glavind, E.B. & Suane, D. Involvement of the L-arginine-nitric oxide pathway in internal anal sphincter relaxation. Gastoenterology 102, 409–415 (1992).
Jin, Y-J. & S.J., Burakoff The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein Kinase II and nucleolin. Proc. natn. Acad. Sci. USA 90, 7769–7773 (1993).
Lebeau, M.C. et al. P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody. J. biol. Chem. 267, 4281–4284 (1992).
Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807–815 (1991).
Friedman, J. & Weissman, I. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 66, 799–806 (1991).
Liu, J. et al. Inhibition of T cell signalling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31, 3896–3901 (1992).
Nelson, P.A. et al. Immunosuppressive activity of [MeBm2t.1-, D-diaminobu-tyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. J. Immunol. 150, 2139–2147 (1993).
Clipston, N.A. & Crabtree, G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357, 695–697 (1992).
O'Keefe, S.J., J., Tamura, R. L. Kincaid, M.J., Tocci & E.A., O'Neill FK-506-and 64. CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357, 692–694 (1992).
Flanagan, W.M., B., Corthesy, R.J., Bram & G.R., Crabtree Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 754–755 (1991).
Kuo, C.J. et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358, 70–73 (1992).
Chung, J.C., J., Kuo, G.R., Crabtree & J., Blenis Rapamycin-FKBP specifically blocks growth-dependent activation of and signalling by the 70 kd S6 protein kinases. Cell 69, 1227–1236 (1992).
Price, D.J., J.R., Grove, V., Calvo, J., Auruch & B.E., Bierer Rapamycin-induced inhi-69. billon of the 70-kilodalton S6 protein kinase. Science 257, 973–977 (1992).
Albers, M.W. et al. An FKBP-rapamycin-sensitive, cyclin-dependent kinase activity that correlates with the FKBP-rapamycin-induced Gl arrest point in MG-63 cells. Ann. N. Y. Acad. Sci. 696, 54–62 (1993).
Jayaraman, T. & A.R., Marks Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line. J. biol. Chem. 268, 25385–25388 (1993).
Morice, W.G., G., Wiederrecht, G.J., Brunn, J.J., Siekierka & R.T., Abraham Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes. J. biol. Chem. 268, 22737–22745 (1993).
Kunz, J. et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for Gl progression. Cell 73, 585–596 (1993).
Heitman, J., N.R., Movva & M.N., Hall Targets for cell cycle arrest by the immuno-suppressant rapamycin in yeast. Science 253, 905–909 (1994).
Sabatini, D.M., H., Erdjument-Bromage, M., Lui, P., Tempst & S.H., Snyder RAFT1 (Rapamycin and FKBP12 Target): a mammalian protein that binds to FKBP12 in rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35–43 (1994).
Brown, E.J. et al. A mammalian protein targeted by Gl-arresting rapamycin-receptor complex. Nature 369, 756–758 (1994).
Chen, Y. et al. A putative sirolimus (rapamycin) effector protein. Biochem. biophys. Res. Commun. 203, 1–7 (1994).
Cantley, L.C. et al. Oncogenes and signal transduction. Cell 64, 281–302 (1991).
Fleischer, S. & M., Inui Biochemistry and biophysics of excitation-contraction coupling. Ann. Rev. Biophys. Biophys. Chem. 18, 333–364 (1989).
Sorrentino, V. & P., Volpe . TIPS 14, 98–102 (1993).
Marks, A.R. et al. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc. natn. Acad. Sci. USA 86, 8683–8687 (1989).
Takeshima, H. et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439–445 (1989).
Otsu, K. et al. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. biol. Chem. 265, 13472–13483 (1990).
Collins, J.H. Sequence analysis of the ryanodine receptor: Possible association with a 12K, FK506-binding immunophilin/protein kinase C inhibitor. Biochem. biophys. Res. Commun. 178, 1288–1290 (1991).
Jayraman, T. et al. FK506 binding protein associated with the calcium release channel (Ryanodine receptor). J. biol. Chem. 267, 9474–9477 (1992).
Brillantes, A.B. et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77, 513–523 (1994).
Ferris, C.D. & S.H., Snyder Inositol 1,4,5-trisphosphate activated calcium channels. Ann. Rev. Physiol. 54, 469–488 (1991).
Berridge, M.J. & R.F., Irvine Inositol phosphates and cell signalling. Nature 341, 197–204 (1989).
Gardner, P. Patch clamp studies of lymphocyte activation. Ann. Rev. Immun. 8, 231–252 (1990).
Khan, A.A., J.P., Steiner, M.G., Klein, M.F., Schneider & S.H., Snyder IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science 257, 815–818 (1992).
Furuichi, T. et al. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342, 32–38 (1989).
Cameron, A.M. et al. Immunophilin FKBP associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc. natn. Acad. Sci. USA .(in the press)
Helekar, S.A., D., Char, S., Neff & J., Patrick Prolyl isomerase requirement for the expression of functional homo-oligomeric ligand-gated ion channels. Neuron 12, 179–189 (1994).
Bram, R.J. & G.R., Crabtree Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature 371, 355–358 (1994).
Wang, T., P.K., Donahoe & A.S., Zervos Specific interaction of type I receptors of the TGF-p family with the immunophilin FFKBP-12. Science 265, 674–676 (1994).
Maki, N., F., Sekiguchi, J., Nishimaki, K., Miwa, T., Hayano, N., Takahashi & M., Suzuki Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. Proc. natn. Acad. Sci. USA 87, 5440–5443 (1990).
Steiner, J.P. et al. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584–587 (1992).
Kuno, T. et al. Distinct cellular expression of calcineurin Aa and Ab in rat brain. J. Neurochem. 58, 1643–1651 (1992).
Jones, D.T. & Reed, R.R. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J. biol. Chem. 262, 14241–14249 (1987).
Dawson, T.M. et al. Immunosuppressant, FK506, enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. natn. Acad. Sci. USA 90, 9808–9812 (1993).
Bredt, D.S. & S.H., Snyder Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. natn. Acad. Sci. USA 86, 9030–9033 (1989).
Garthwaite, J., G., Garthwaite, R.M.J., Palmer & S., Moncada NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmac. 172, 413–416 (1989).
Bredt, D.S. & S.H., Synder Isolation of nitric oxide synthetase, a calmodulin-re-quiring enzyme. Proc. natn. Acad. Sci. USA 87, 682–685 (1990).
Choi, D.W. Bench to bedside: the glutamate connection. Science 258, 241–243 (1992).
Bredt, D.S., C.D., Ferris & S.H., Snyder Nitric oxide synthase regulatory sites. J. biol. Chem. 267, 10976–10981 (1992).
Dinerman, J.L. & S.H., Snyder Multiple phosphorylations of neuronal nitric oxide synthase inhibit catalytic activity. Neuropharm. (1994).(in the press)
Sharkey, J. & S.P., Butcher Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371, 336–339 (1994).
Meiri, K.F., L.E., Bickerstaff & J.E., Schwob Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J. cell Biol. 112, 991–1005 (1991).
Lyons, W.E., E.B., George, T.M., Dawson, J.P., Steiner & S.H., Snyder Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC-12 cells and sensory ganglia. Proc. natn. Acad. Sci. USA 91, 3191–3195 (1994).
Gold, B.G., T., Storm-Dickerson & D.R., Austin The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restorative Neurol. Neurosci. 6, 287–296 (1994).
Lyons, W.E., J.P., Steiner, S.H., Snyder & T.M., Dawson Neuronal regeneration enhances the expression of the immunophilin FKBP. J. Neurosci. (1994).(in the press)
Hultsch, T., M.W., Albers, S.L., Schreiber & R.J., Hohman Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. Proc. natn. Acad. Sci. USA 88, 6229–6233 (1991).
Steiner, J.P., T.M., Dawson & S.H., Snyder Immunophilin regulation of neuro-transmitter release. Soc. Neurosci. Abst. (1993). (Abstract)
Hirsch, D.B., J.P., Steiner, T.M., Dawson, A., Mammen, E., Hayek & S.H., Snyder Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synap-tosomes. Cur. Biol. 3, 749–754 (1993).
Hanbauer, L., D., Wink, Y., Osawa, G.M., Edelman & J., Gaily Role of nitric oxide in NMDA-evoked release of [3H]dopamine from striatal slices. NeuroReport 3, 409–412 (1992).
Luban, J. et al. Cell 73, 1067–1078 (1993).
Francke, E.K. et al. Nature 372, 359–360 (1994).
Thali, M. et al. Nature 372, 363–364 (1994).
Stancato, L.F. et al. J. biol. Chem. 269, 22157–22161 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snyder, S., Sabatini, D. Immunophilins and nervous system. Nat Med 1, 32–37 (1995). https://doi.org/10.1038/nm0195-32
Issue Date:
DOI: https://doi.org/10.1038/nm0195-32
This article is cited by
-
The Role of FK506-Binding Proteins 12 and 12.6 in Regulating Cardiac Function
Pediatric Cardiology (2012)
-
Transduced PEP-1-FK506BP Ameliorates Atopic Dermatitis in NC/Nga Mice
Journal of Investigative Dermatology (2011)
-
FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes
Rheumatology International (2011)
-
Effects of water-soluble tacrolimus-PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus
Archives of Pharmacal Research (2011)
-
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
Nature Medicine (1999)